专题:PI3K/AKT/mTOR signaling in cancer

This cluster of papers focuses on the mTOR signaling pathway, particularly its role in growth control, metabolism, and disease, with a specific emphasis on cancer. The PI3K/AKT pathway, Raptor, TSC2, and rapamycin are central to the research discussed in these papers.
最新文献
CML-1217: Unexplained Dyspnea in a CML Patient: Recognizing Dasatinib-Associated Pulmonary Artery Hypertension

article Full Text OpenAlex

Unexpected Severe Hyperglycemic State in a Nondiabetic Patient on Capivasertib Therapy

article Full Text OpenAlex

Osimertinib-related myotoxicity: a disproportionality analysis of the FDA adverse event reporting system

article Full Text OpenAlex

Taletrectinib in ROS1 Fusion–Positive Non–Small Cell Lung Cancer: Promising Yet Premature?

letter Full Text OpenAlex

Suppression of Sebum Production by Vemurafenib Through Paradoxical ERK Activation Resulted in the Inhibition of the mTOR Pathway in 5α‐Dihydrotestosterone‐Differentiated Hamster Sebocytes In Vitro

article Full Text OpenAlex

Flavonoids as Promising Akt1 Inhibitors in Cancer Medicine: Insights From Molecular Docking, Dynamics, DFT Calculations, and In Vitro Validation

article Full Text OpenAlex

Translational Inhibition of Slug by Pdcd4 Contributes to Invasion Inhibition in Colorectal Cancer Cells

article Full Text OpenAlex

The Role of PTEN Tumor Suppressor Genes in Endometrial Cancer

article Full Text OpenAlex

Phase 2 Study of Zilovertamab Vedotin in Participants With Metastatic Solid Tumors

article Full Text OpenAlex

Dermatologic adverse events in patients receiving duvelisib single-agent and combination therapies.

article Full Text OpenAlex

近5年高被引文献
Targeting PI3K/Akt signal transduction for cancer therapy

review Full Text OpenAlex 1157 FWCI20.757

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

review Full Text OpenAlex 1054 FWCI54.747

Kinase drug discovery 20 years after imatinib: progress and future directions

review Full Text OpenAlex 856 FWCI36.089

Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRAS G12C Mutation

article Full Text OpenAlex 684 FWCI64.172

PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?

review Full Text OpenAlex 563 FWCI18.825

Regulation and metabolic functions of mTORC1 and mTORC2

review Full Text OpenAlex 558 FWCI12.355

Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

review Full Text OpenAlex 488 FWCI24.984

Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

review Full Text OpenAlex 476 FWCI9.456

Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer

article Full Text OpenAlex 442 FWCI138.216

PI3K inhibitors are finally coming of age

review Full Text OpenAlex 375 FWCI9.105